DQ Energy, L.P.

Houston, TX November 28, 2016 -- DermaClip US, LLC today announced that the IRB-approved clinical trial has completed over half of the 32 patients using the  DermaClip Skin Closure Device to do final stage skin closure of Caesarean Sections, with outstanding results so far.  Charles Darling, CEO of DermaClip US stated, "We continue to be excited about this trial.  During the past several months had exhibits at the AORN Conference, AOHN Conference, the Plastic Surgeons Conference, as well as chosen by Vizient to participate in their show and the US Army Medical Material Agency. The use of DermaClip Internationally continues to show it to be a major step forward in ease-of-use, end results and patient satisfaction."